Nitric Oxide Synthase Type III
"Nitric Oxide Synthase Type III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in ENDOTHELIAL CELLS.
Descriptor ID |
D052250
|
MeSH Number(s) |
D08.811.682.664.500.772.750
|
Concept/Terms |
Nitric Oxide Synthase Type III- Nitric Oxide Synthase Type III
- Nitric Oxide Synthase, Type III
- Endothelial Nitric Oxide Synthase
- ENOS Enzyme
- ECNOS Enzyme
- Endothelial Constitutive Nitric Oxide Synthase
|
Below are MeSH descriptors whose meaning is more general than "Nitric Oxide Synthase Type III".
Below are MeSH descriptors whose meaning is more specific than "Nitric Oxide Synthase Type III".
This graph shows the total number of publications written about "Nitric Oxide Synthase Type III" by people in this website by year, and whether "Nitric Oxide Synthase Type III" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 0 | 1 | 1 | 2009 | 0 | 2 | 2 | 2010 | 0 | 1 | 1 | 2011 | 1 | 1 | 2 | 2013 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitric Oxide Synthase Type III" by people in Profiles.
-
Ishikawa T, Yuhanna IS, Umetani J, Lee WR, Korach KS, Shaul PW, Umetani M. LXRß/estrogen receptor-a signaling in lipid rafts preserves endothelial integrity. J Clin Invest. 2013 Aug; 123(8):3488-97.
-
Sundgren NC, Zhu W, Yuhanna IS, Chambliss KL, Ahmed M, Tanigaki K, Umetani M, Mineo C, Shaul PW. Coupling of Fc? receptor I to Fc? receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function. Circ Res. 2011 Oct 28; 109(10):1132-40.
-
Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol. 2011 Sep 30; 667(1-3):258-64.
-
Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010 Jul; 120(7):2319-30.
-
Banday AA, Lokhandwala MF. Inhibition of natriuretic factors increases blood pressure in rats. Am J Physiol Renal Physiol. 2009 Aug; 297(2):F397-402.
-
Lu J, Yang JH, Burns AR, Chen HH, Tang D, Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res. 2009 Mar 13; 104(5):619-27.
-
Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007 Oct; 13(10):1185-92.
|
People ![Expand Description](http://scholarprofile.org/Framework/Images/info.png) People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|